News & Updates

Show Multimedia Only
Burden of microvascular disease elevates atrial fibrillation risk in T2D patients Burden of microvascular disease elevates atrial fibrillation risk in T2D patients

Burden of microvascular disease elevates atrial fibrillation risk in T2D patients

05 Sep 2022

The presence and the burden of microvascular disease in adults with type 2 diabetes (T2D) independently contribute to an increased risk of incident atrial fibrillation (AF), suggests a recent study.

05 Sep 2022
Visceral fat alters baPWV in T2DM, promotes left ventricular remodeling

Visceral fat alters baPWV in T2DM, promotes left ventricular remodeling

04 Sep 2022

In patients with type 2 diabetes mellitus (T2DM), the impact of visceral fat (VF) on left ventricular remodeling (LVRM) can be attributed to changes in brachial-ankle pulse wave velocity (baPWV), a new study reports.

04 Sep 2022
Glaucoma risk modestly low in diabetes

Glaucoma risk modestly low in diabetes

04 Sep 2022

Patients with diabetes mellitus are at reduced risk of developing open-angle glaucoma (OAG), although the magnitude of reduction is modest, according to a study.

04 Sep 2022
Liraglutide boosts lipid metabolism in T2DM, but comes with more side effects

Liraglutide boosts lipid metabolism in T2DM, but comes with more side effects

02 Sep 2022

Compared with dapagliflozin, the glucagon-like peptide 1 liraglutide induces better lipid metabolism in patients with type 2 diabetes mellitus (T2DM), a recent study has found. However, this drug also comes with more adverse events than its sodium-glucose co-transporter 2 inhibitor comparator.

02 Sep 2022